牛瑞芳,钟顺莲,沙仁高娃

在子宫内膜癌（Endometrial Cancer，EC）中，有无淋巴结转移是子宫内膜癌患者预后的一个重要参考指标，术前分类基于组织病理学标准对淋巴结转移（Lymph Node Metastasis，LNM）的风险仅具有中等的诊断性能。目前各类分子标志物表现出了不逊色于经典临床病理参数的良好预测价值，现本文针对术前临床分子标志物在子宫内膜癌淋巴结转移中的预测价值这一问题予以综述。

子宫内膜癌；淋巴结转移；分子标志物；炎症指标；预测模型；分子分型

[1] Amant F,Moerman P,Neven P,Timmerman D,Van Limbergen E,Vergote I.Endometrial cancer.Lancet.2005 Aug 6-12;366(9484):491-505. [2] Creasman WT,Morrow CP,Bundy BN,Homesley HD,Graham JE,Heller PB.Surgical pathologic spread patterns of endometrial cancer.A Gynecologic Oncology Group Study.Cancer.1987 Oct 15;60(8 Suppl):2035-41. [3] Berek JS,Matias-Guiu X,Creutzberg C,Fotopoulou C,Gaffney D,Kehoe S,Lindemann K,Mutch D,Concin N;Endometrial Cancer Staging Subcommittee,FIGO Women's Cancer Committee.FIGO staging of endometrial cancer:2023.Int J Gynaecol Obstet.2023 Aug; 162(2):383-394. [4] Ignatov A,Lebius C,Ignatov T,Ivros S,Knueppel R,Papathemelis T,Ortmann O,Eggemann H.Lymph node micrometastases and outcome of endometrial cancer.Gynecol Oncol.2019 Sep;154(3):475-479. [5] Colombo N,Creutzberg C,Amant F,Bosse T,González-Martín A,Ledermann J,Marth C,Nout R,Querleu D,Mirza MR,Sessa C; ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer:diagnosis,treatment and follow-up.Ann Oncol.2016 Jan;27(1):16-41. [6] Visser NCM,Reijnen C,Massuger LFAG,Nagtegaal ID,Bulten J,Pijnenborg JMA.Accuracy of Endometrial Sampling in Endometrial Carcinoma:A Systematic Review and Meta-analysis.Obstet Gynecol.2017 Oct;130(4):803-813. [7] de Freitas D,Aguiar FN,Anton C,de Almeida DC,Bacchi CE,Carvalho JP,Carvalho FM.Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status.Heliyon.2023 Jun 22;9(6). [8] Kim MK,So KA,Chun YK,Kim YH,Lim KT,Lee KH,Kim TJ.Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer.Taiwan J Obstet Gynecol.2023 Sep;62(5):724-728. [9] Niloff JM,Klug TL,Schaetzl E,Zurawski VR Jr,Knapp RC,Bast RC Jr.Elevation of serum CA125 in carcinomas of the fallopian tube,endometrium,and endocervix.Am J Obstet Gynecol.1984 Apr 15;148(8):1057-8. [10] Yildiz A,Yetimalar H,Kasap B,Aydin C,Tatar S,Soylu F,Yildiz FS.Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma.Eur J Obstet Gynecol Reprod Biol.2012 Oct;164(2):191-5. [11] Han SS,Lee SH,Kim DH,Kim JW,Park NH,Kang SB,Song YS.Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.Acta Obstet Gynecol Scand.2010;89(2):168-74. [12] Jiang T,Huang L,Zhang S.Preoperative serum CA125:a useful marker for surgical management of endometrial cancer.BMC Cancer. 2015 May 12;15:396. [13] Morice P,Leary A,Creutzberg C,Abu-Rustum N,Darai E.Endometrial cancer.Lancet.2016 Mar 12;387(10023):1094-1108. [14] Pinton G,Manzotti B,Balzano C,Moro L.Expression and clinical implications of estrogen receptors in thoracic malignancies:a narrative review.J Thorac Dis.2021 Mar;13(3):1851-1863. [15] Wang C,Tran DA,Fu MZ,Chen W,Fu SW,Li X.Estrogen Receptor,Progesterone Receptor,and HER2 Receptor Markers in Endometrial Cancer.J Cancer.2020 Jan 16;11(7):1693-1701. [16] Przewoźny S,Rogaliński J,de Mezer M,Markowska A,Markowska J,Żurawski J.Estrogen Receptor(ER)and Progesterone Receptor (PgR)Expression in Endometrial Cancer-An Immunohistochemical Assessment.Diagnostics(Basel).2024 Feb 1;14(3):322. [17] Vrede SW,Van Weelden WJ,Bulten J,Gilks CB,Teerenstra S,Huvila J,Matias-Guiu X,Gil-Moreno A,Asberger J,Sweegers S,van der Putten LJM,Küsters-Vandevelde HVN,Reijnen C,Colas E,HausnerováJ,Weinberger V,Snijders MPLM,Vinklerova P,Ravaggi A,Odicino F,Bignotti E,McAlpine JN,Kruitwagen R,Pijnenborg JMA.Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.Gynecol Oncol.2025 Jan;192:15-23. [18] Balkwill F,Mantovani A.Inflammation and cancer:back to Virchow?Lancet.2001 Feb 17;357(9255):539-45. [19] Mantovani A,Allavena P,Sica A,Balkwill F.Cancer-related inflammation.Nature.2008 Jul 24;454(7203):436-44. [20] Zhong JH,Huang DH,Chen ZY.Prognostic role of systemic immune-inflammation index in solid tumors:a systematic review and meta-analysis.Oncotarget.2017 Jun 29;8(43):75381-75388. [21] Olingy CE,Dinh HQ,Hedrick CC.Monocyte heterogeneity and functions in cancer.J Leukoc Biol.2019 Aug;106(2):309-322. [22] Szebeni GJ,Vizler C,Nagy LI,Kitajka K,Puskas LG.Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.Int J Mol Sci.2016 Nov 23;17(11):1958. [23] Li T,Wu B,Yang T,Zhang L,Jin K.The outstanding antitumor capacity of CD4+T helper lymphocytes.Biochim Biophys Acta Rev Cancer.2020 Dec;1874(2):188439. [24] Ahn JH,Lee SJ,Yoon JH,Park DC,Kim SI.Prognostic value of pretreatment systemic inflammatory markers in patients with stage I endometrial cancer.Int J Med Sci.2022 Nov 7;19(14):1989-1994. [25] Ni L,Tao J,Xu J,Yuan X,Long Y,Yu N,Wu R,Zhang Y.Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet- to-lymphocyte ratios in endometrial cancer:a systematic review and meta-analysis.Arch Gynecol Obstet.2020 Jan;301(1):251-261. [26] Xiong Y,Yong Y,Wang Y.Clinical value of hemoglobin,albumin,lymphocyte,and platelet indexes in predicting lymph node metastasis and recurrence of endometrial cancer:a retrospective study.PeerJ.2023 Sep 27;11:e16043. [27] Ronsini C,Iavarone I,Vastarella MG,Della Corte L,Andreoli G,Bifulco G,Cobellis L,De Franciscis P.SIR-EN-New Biomarker for Identifying Patients at Risk of Endometrial Carcinoma in Abnormal Uterine Bleeding at Menopause.Cancers(Basel).2024 Oct 23; 16(21):3567. [28] Terlikowska KM,Dobrzycka B,Terlikowski R,Sienkiewicz A,Kinalski M,Terlikowski SJ.Clinical value of selected markers of angiogenesis,inflammation,insulin resistance and obesity in type 1 endometrial cancer.BMC Cancer.2020 Sep 25;20(1):921. [29] Zhang B,Zhou D,Zhang S,Yan J,Meng Q,Lv Q.Clinical analysis of molecular typing of 146 cases of endometrial carcinoma.Front Oncol.2025 Jan 20;14:1482817. [30] Alexa M,Hasenburg A,Battista MJ.The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions.Cancers(Basel).2021 Mar 23;13(6):1478. [31] Arciuolo D,Travaglino A,Raffone A,Raimondo D,Santoro A,Russo D,Varricchio S,Casadio P,Inzani F,Seracchioli R,Mollo A,Mascolo M,Zannoni GF.TCGA Molecular Prognostic Groups of Endometrial Carcinoma:Current Knowledge and Future Perspectives.Int J Mol Sci.2022 Oct 2;23(19):11684. [32] Talhouk A,McConechy MK,Leung S,Yang W,Lum A,Senz J,Boyd N,Pike J,Anglesio M,Kwon JS,Karnezis AN,Huntsman DG,Gilks CB,McAlpine JN.Confirmation of ProMisE:A simple,genomics-based clinical classifier for endometrial cancer.Cancer.2017 Mar 1;123(5):802-813. [33] Iavarone I,Molitierno R,Fumiento P,Vastarella MG,Napolitano S,Vietri MT,De Franciscis P,Ronsini C.MicroRNA Expression in Endometrial Cancer:Current Knowledge and Therapeutic Implications.Medicina(Kaunas).2024 Mar 15;60(3):486. [34] Frost JA,Webster KE,Morrison J.Lymphadenectomy for Treatment of Early-Stage Endometrial Cancer.JAMA Oncol.2017 Jan 1;3(1):117-118. [35] Li H,Wang J,Zhang G,Li L,Shen Z,Zhai Z,Wang Z,Wang J.Predictive models for lymph node metastasis in endometrial cancer:A systematic review and bibliometric analysis.Womens Health(Lond).2024 Jan-Dec;20:17455057241248398. [36] Reticker-Flynn NE,Zhang W,Belk JA,Basto PA,Escalante NK,Pilarowski GOW,Bejnood A,Martins MM,Kenkel JA,Linde IL,Bagchi S,Yuan R,Chang S,Spitzer MH,Carmi Y,Cheng J,Tolentino LL,Choi O,Wu N,Kong CS,Gentles AJ,Sunwoo JB,Satpathy AT,Plevritis SK,Engleman EG.Lymph node colonization induces tumor-immune tolerance to promote distant metastasis.Cell.2022 May 26;185(11):1924-1942.e23. [37] Jamieson A,Thompson EF,Huvila J,Leung S,Lum A,Morin C,Ennour-Idrissi K,Sebastianelli A,Renaud MC,Gregoire J,Huntsman DG,Gilks CB,Plante M,Grondin K,McAlpine JN.Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.Gynecol Oncol.2022 May;165(2):376-384. [38] Guo X,Lin C,Zhao J,Tang M.Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma.BMC Cancer.2022 Dec 20;22(1):1333.

点击下载PDF